Icariin improves memory impairment in Alzheimer's disease model mice (5xFAD) and attenuates amyloid β‐induced neurite atrophy
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Essential therapeutic drugs for Alzheimer's disease (AD) have not been developed. Since the neuritic atrophy leading to synaptic losses is one of the critical causes of memory impairment in AD, the effects of several constituents in tonic herbal medicines on neuritic atrophy and memory deficits have been studied. The present study investigated the effects of icariin, a main constituent in Epimedii Herba, a well known tonic crude drug, in an in vitro AD model and transgenic mouse AD model (5xFAD). Amyloid β(1–42)‐induced atrophies of axons and dendrites were restored by post‐treatment with icariin in rat cortical neurons. Administration of icariin for 8 days (p.o.) improved spatial memory impairment in 5xFAD mice. These novel findings suggest that icariin may improve memory dysfunction in AD and have a potential to extend neurites even when amyloid β‐induced neurite atrophy has already occurred. Copyright © 2010 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 11×
“, 2004), gliosis, synapse loss and memory impairment (Oakley et al., 2006) occur in 5xFAD mice brain.”
BackgroundResultInfluentialScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Intraneuronal Aβ42 Accumulation in Human Brain
Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991 · cited 1×
“Aβ plaque is accumulated in the brain of AD cases (Takahashi et al., 2004; Gouras et al., 2000), and induces several of the pathologies of AD (Echeverria and Cuello, 2002; Tseng et al., 2004; Gouras et al., 2005).”
BackgroundAnimal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676
Synaptic degeneration in Alzheimer's disease
Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517 · cited 2×
“Also in AD patients, it is supposed that neuronal death is not the direct cause of memory dysfunction, and the synaptic loss which begins at an early stage may be a major trigger of memory impairment (Bertoni-Freddari et al., 2003; Arendt, 2009).”
BackgroundOligomerization of Alzheimer's β-Amyloid within Processes and Synapses of Cultured Neurons and Brain
Takahashi, R. H., Almeida, C. G., Kearney, P. F., Yu, F., Lin, M. T., Milner, T. A., & Gouras, G. K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5167-03.2004 · Cited by 445 · cited 2×
“Aβ plaque is accumulated in the brain of AD cases (Takahashi et al., 2004; Gouras et al., 2000), and induces several of the pathologies of AD (Echeverria and Cuello, 2002; Tseng et al., 2004; Gouras et al., 2005).”
BackgroundCasas, C., Sergeant, N., Itier, J.-M., Blanchard, V., Wirths, O., van der Kolk, N., Vingtdeux, V., van de Steeg, E., Ret, G., Canton, T., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63388-3 · Cited by 400
Neuritic regeneration and synaptic reconstruction induced by withanolide A
Kuboyama, T., Tohda, C., & Komatsu, K. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706122 · Cited by 339 · cited 1×
“Studies previously focused on the memory enhancement effects of several tonic herbal medicine-derived steroidal saponins and those of sapogenin (Kuboyama et al., 2005, 2006; Tohda et al., 2004; Tohda and Joyashiki, 2009) and investigated the molecular mechanisms of these compounds (Tohda et al.,…”
BackgroundIntraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease
Gouras, G. K., Almeida, C. G., & Takahashi, R. H. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.022 · Cited by 338 · cited 1×
“Aβ plaque is accumulated in the brain of AD cases (Takahashi et al., 2004; Gouras et al., 2000), and induces several of the pathologies of AD (Echeverria and Cuello, 2002; Tseng et al., 2004; Gouras et al., 2005).”
BackgroundKimura, R., & Ohno, M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.006 · Cited by 333
Dickson, T. C., & Vickers, J. C. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00169-5 · Cited by 294 · cited 2×
“Not only neuronal death but also neuritic atrophy and synaptic loss underlie the pathogenesis of AD patients (Dickson and Vickers, 2001) as direct causes of the memory defi cit.”
BackgroundBACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice
Ohno, M., Cole, S. L., Yasvoina, M., Zhao, J., Citron, M., Berry, R., Disterhoft, J. F., & Vassar, R. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.008 · Cited by 290
Schmitz, C., Rutten, B. P. F., Pielen, A., Schäfer, S., Wirths, O., Tremp, G., Czech, C., Blanchard, V., Multhaup, G., Rezaie, P., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63235-x · Cited by 281 · cited 5×
“Overexpression of Aβ results in the production of Aβ plaque and soluble Aβ oligomers, and induces progressive neuronal death in the cerebral cortex and hippocampus and causes memory impairment in several lines of transgenic AD model mice (Berger-Sweeney et al., 1999; Casas et al., 2004; Schmitz et al., 2004).”
BackgroundInfluentialWithanoside IV and its active metabolite, sominone, attenuate Aβ(25–35)‐induced neurodegeneration
Kuboyama, T., Tohda, C., & Komatsu, K. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04664.x · Cited by 171 · cited 3×
“v) mouse model (Kuboyama et al., 2006) and another report (Evans et al.”
BackgroundSelf-citationGenetics of Alzheimer's disease
Hutton, M., Pérez-Tur, J., & Hardy, J. (1998) · Essays in Biochemistry · doi:10.1042/bse0330117 · Cited by 88
Function and Dysfunction of the Presenilins
Sisodia, S. S., Kim, S. H., & Thinakaran, G. (1999) · The American Journal of Human Genetics · doi:10.1086/302475 · Cited by 76 · cited 4×
“Aβ(1–42) induces more potent neuronal injury than does Aβ(1–40) (Glenner and Wong, 1984; Hutton et al., 1998; Sisodia et al., 1999).”
BackgroundInfluentialAmyloid β-Peptide: The Inside Story
Tseng, B., Kitazawa, M., & LaFerla, F. (2004) · Current Alzheimer Research · doi:10.2174/1567205043332045 · Cited by 72
Tohda, C., & Joyashiki, E. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00313.x · Cited by 62
Self-citation
Cited by
Webster, S. J., Bachstetter, A. D., Nelson, P. T., Schmitt, F. A., & Van Eldik, L. J. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00088 · Cited by 755
“This model develops cognitive deficits by 3 months of age in spatial working memory (Ohno et al., 2006; Urano and Tohda, 2010).”
MethodRichard, B. C., Kurdakova, A., Baches, S., Bayer, T. A., Weggen, S., & Wirths, O. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-143120 · Cited by 142
Girard, S. D., Jacquet, M., Baranger, K., Migliorati, M., Escoffier, G., Bernard, A., Khrestchatisky, M., Féron, F., Rivera, S., Roman, F. S., et al. (2014) · Hippocampus · doi:10.1002/hipo.22267 · Cited by 119
The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer’s disease
Kalinin, S., Polak, P. E., Lin, S. X., Sakharkar, A. J., Pandey, S. C., & Feinstein, D. L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.012 · Cited by 116
“…month-old 5xFAD mice showed worse learning than wild-type littermates after 12 sessions of 2 trials each over 4 days (Ohno et al., 2006); while in a recent study 7- to 9-month-old female 5xFAD mice did not show any improvement after being trained 4 times per day for 9 days (Urano and Tohda, 2010).”
BackgroundMethodLiu, D.-S., Pan, X.-D., Zhang, J., Shen, H., Collins, N. C., Cole, A. M., Koster, K. P., Ben Aissa, M., Dai, X.-M., Zhou, M., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0002-2 · Cited by 99
Metadata
- Authors
- Urano, T., & Tohda, C.
- Venue
- Phytotherapy Research
- Publisher
- Wiley
- Published
- 2010-10-28
- Volume
- 24
- Issue
- 11
- Pages
- 1658-1663
- ISSN
- 0951-418X (ISSN-L)
- 1099-1573
- OpenAlex
- W2032411692
- Cited by
- 101
- References
- 18
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.